Product Information
FLUVOXAMINE ER 100 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $4.8709 per EA under NDC 00228284803. Its NADAC has been published 611 times since Oct 15, 2014.
Strength
100 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228284803
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FLUVOXAMINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA091482On Market Since
8/5/2014
Pharmacological Classes
Price Statistics
The NADAC for FLUVOXAMINE ER 100 MG CAPSULE has been published 611 times since Oct 15, 2014, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8709 per EA |
|---|---|
| All-time high | $7.5266 (Mar 11, 2015) |
| All-time low | $3.4392 (Apr 17, 2024) |
| 52-week high | $5.4642 |
| 52-week low | $4.7418 |
| Median price | $6.2229 |
| Average price | $6.1024 |
| Largest weekly change | -39.6% (Apr 17, 2024) |
| Weeks tracked | 611 |
| Tracking since | Oct 15, 2014 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FLUVOXAMINE ER 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FLUVOXAMINE ER 100 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $4.8709 per EA (NDC 00228284803), effective Jun 24, 2026.
How has the price of FLUVOXAMINE ER 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FLUVOXAMINE ER 100 MG CAPSULE has declined 34.6%. It has been tracked across 611 weekly CMS publications since Oct 15, 2014.
What are the highest and lowest recorded NADAC prices for FLUVOXAMINE ER 100 MG CAPSULE?
Since Oct 15, 2014, the NADAC for FLUVOXAMINE ER 100 MG CAPSULE has ranged from a low of $3.4392 (Apr 17, 2024) to a high of $7.5266 (Mar 11, 2015), with a median of $6.2229 per EA.
Are there cheaper alternatives to FLUVOXAMINE ER 100 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, FLUVOXAMINE MALEATE 100 MG TAB, is $0.2453 per EA — about 95% below FLUVOXAMINE ER 100 MG CAPSULE.
Who manufactures FLUVOXAMINE ER 100 MG CAPSULE?
FLUVOXAMINE ER 100 MG CAPSULE (NDC 00228284803) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification